Grieving parents whose sons died after using kratom are raising alarms about the substance, criticizing federal health regulators for softening recommendations on synthetic compounds derived from the plant, CBS News reported.
Susan Eppard recalled to “60 Minutes” that her son Matthew believed kratom was harmless, comparing its effects to coffee because the plant belongs to the coffee family. Matthew collapsed suddenly while playing cards with friends. Toxicological testing later attributed his death solely to mitragynine, the primary opioid ingredient found in kratom.
Other parents shared similar stories of loss. Patti Wheeler said her son Wyatt used kratom to help ease away from alcohol. Wendy Chamberlain noted her son Joe was told by a friend that kratom was safer than an energy drink. Joe’s death was also linked exclusively to mitragynine. The deaths of Wyatt Wheeler and Daniel Bregger were attributed to mitragynine combined with prescription or over-the-counter medications.
Rising Overdose Fatalities and Health Warnings
Kratom comes from a Southeast Asian tree and acts on opioid receptors in the human brain. The product has fueled a billion-dollar U.S. industry, sold online and in tens of thousands of gas stations and smoke shops nationwide. While distributors market kratom as a mild energy boost or an aid for recovering from opioid addiction, medical professionals warn of severe addiction and fatal risks.
Between 2020 and 2024, the Centers for Disease Control and Prevention identified kratom in more than 5,000 overdose deaths. Justin Brower, a toxicologist at NMS Labs outside Philadelphia, told “60 Minutes” that fatal incidents involving kratom have increased roughly tenfold since 2014, with dozens of cases caused by kratom alone. The Food and Drug Administration continues to urge consumers to avoid kratom due to risks of liver toxicity, seizures, and substance use disorder.
Shift in Federal Guidance and Industry Lobbying
Federal scrutiny heightened in July when officials proposed restrictions on 7-OH, a concentrated synthetic substance related to kratom, alongside three related compounds. However, the U.S. Department of Health and Human Services adjusted its stance last month, recommending a 20-fold increase in the allowable concentration of 7-OH in products, according to CBS News.
The policy shift stunned medical experts, including former FDA Commissioner Dr. Marty Makary and former senior HHS advisor Calley Means. Public filings reviewed by “60 Minutes” reveal that the American Kratom Association and industry allies have spent millions of dollars over the past decade lobbying the White House, Congress, HHS, and the FDA to maintain legal sales.
Dr. Andrew Kolodny, who directs Brandeis University’s Opioid Policy Research Collaborative, compared the industry’s lobbying strategy to tactics used by OxyContin manufacturer Purdue Pharma, noting that paid scientists downplay safety risks while exaggerating benefits.
Regulatory Stance and Ongoing Debate
HHS said in a statement that political contributions or outside lobbying had no bearing on its revised recommendations for 7-OH levels. Meanwhile, the American Kratom Association defended natural kratom as a safe herbal supplement, drawing a distinction between raw botanical products and chemically altered derivatives.
Eppard said she continues visiting convenience stores to inform employees about the dangers of the products on their shelves, hoping to prevent further tragedies as federal regulators review rules governing kratom compounds.



